Chen Bihua
Transactions
50
Companies
41
Filings
4
CIK
0001599214
Recent Transactions
- Purchase
- Award
- Award
- Other
- Other
- Sale
- Sale
- Sale
- Sale
Class A Ordinary Shares
2025-09-29$7.58/sh−3,390,943→ 4,800,000 total - Sale
Class A Ordinary Shares
2025-09-29$6.61/sh−2,800,000→ 2,000,000 total - Award
- Award
- Award
Common Stock
2025-08-11$10.72/sh+5,598,425→ 5,667,785 total - Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
Class B ordinary shares
2025-08-11−307,874→ 4,172,126 total - Award
- Other
- Award
- Award
Class A Ordinary Shares
2024-02-13$10.00/sh+509,000→ 509,000 total - Purchase
Class A Ordinary Shares
2024-02-13$10.00/sh+903,600→ 903,600 total - Purchase
Class A Ordinary Shares
2024-02-13$10.00/sh+69,360→ 69,360 total - Purchase
Class A Ordinary Shares
2024-02-13$10.00/sh+1,427,040→ 1,427,040 total - Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
Companies
41- $AARD
Aardvark Therapeutics, Inc.
Former 10% Owner
Akouos, Inc.
Director, 10% Owner
Ambrx Biopharma Cayman, Inc.
10% Owner
Ambrx Biopharma, Inc.
10% Owner
- $APLS
Apellis Pharmaceuticals, Inc.
Director, 10% Owner
- $AVIR
Atea Pharmaceuticals, Inc.
Director, 10% Owner
- $RNA
Avidity Biosciences, Inc.
Director, 10% Owner
Axonics, Inc.
Director, 10% Owner
- $BIOA
BioAge Labs, Inc.
Former 10% Owner
- $BCAB
BioAtla, Inc.
Director, 10% Owner
- $BMEA
Biomea Fusion, Inc.
Director, 10% Owner
- $BBOT
BridgeBio Oncology Therapeutics, Inc.
Director, 10% Owner
- $DRUG
BRIGHT MINDS BIOSCIENCES INC.
10% Owner
- $CLRB
Cellectar Biosciences, Inc.
Director, 10% Owner
- $CLSDQ
Clearside Biomedical, Inc.
Director, 10% Owner
CONSTELLATION PHARMACEUTICALS INC
Director, 10% Owner
- $CRBP
Corbus Pharmaceuticals Holdings, Inc.
10% Owner
- $DSGN
Design Therapeutics, Inc.
Director, 10% Owner
Elevation Oncology, Inc.
10% Owner
- $ERAS
Erasca, Inc.
Director, 10% Owner
- $EYPT
EyePoint, Inc.
10% Owner
GreenLight Biosciences Holdings, PBC
See below
- $HLXC
Helix Acquisition Corp. III
Director, Chairperson and CEO, 10% Owner
Icosavax, Inc.
Former 10% Owner
- $IMRX
Immuneering Corp
10% Owner
- $JBIO
Jade Biosciences, Inc.
Former 10% Owner
- $KZR
Kezar Life Sciences, Inc.
Director, 10% Owner
KINETA, INC./DE
Director, 10% Owner
- $KNSA
Kiniksa Pharmaceuticals International, plc
Director, 10% Owner
- $GLUE
Monte Rosa Therapeutics, Inc.
10% Owner
- $MLTX
MoonLake Immunotherapeutics
Former 10% Owner
- $OLMA
Olema Pharmaceuticals, Inc.
Director, 10% Owner
- $OKUR
OnKure Therapeutics, Inc.
10% Owner
Prometheus Biosciences, Inc.
Director, 10% Owner
- $PYXS
Pyxis Oncology, Inc.
10% Owner
Rain Oncology Inc.
Director
Turning Point Therapeutics, Inc.
Director, 10% Owner
- $TYRA
Tyra Biosciences, Inc.
10% Owner
- $VTYX
Ventyx Biosciences, Inc.
Former 10% Owner
Verve Therapeutics, Inc.
Director, 10% Owner
Vigil Neuroscience, Inc.
10% Owner
Recent Filings
4Address
C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON ST, 52ND FLOOR
BOSTON, MA, 02116